# DESCRIPTION

## TECHNICAL FIELD

- introduce rheumatoid arthritis and its evaluation methods

## BACKGROUND ART

- describe rheumatoid arthritis and its effects
- discuss limitations of current disease activity evaluation methods
- summarize existing biomarkers and their limitations
- describe the need for a simple and accurate evaluation method
- motivate the development of a new evaluation method

## SUMMARY OF THE INVENTION

### Problems to be Solved by the Invention

- state objectives

### Mean for Solving the Problems

- focus on MMP-3 in serum
- find correlation between MMP-3 and disease activity
- identify glycan structure change in MMP-3
- develop method to detect glycan structure change
- use lectin array to analyze glycan structure
- identify Jacalin as key lectin
- find inverse correlation between Jacalin signal and disease activity
- develop method to evaluate disease activity using Jacalin signal
- verify method using synovial fluid samples
- expand method to other body fluids
- develop kit for evaluating disease activity
- apply method to other rheumatic diseases
- define biomarkers for rheumatoid arthritis
- describe methods for determining disease activity
- outline reagents and kits for assessing disease activity
- specify methods for diagnosing polymyalgia rheumatica and relapsing polychondritis
- detail methods for diagnosing rheumatoid arthritis

### Effects of the Invention

- summarize benefits

## MODES FOR CARRYING OUT THE INVENTION

### 1. Glycan Biomarker for Rheumatoid Arthritis in the Present Invention

- define MMP-3 and its role in rheumatoid arthritis
- describe Jacalin-binding glycan as a biomarker for rheumatoid arthritis
- explain structure and function of MMP-3 glycan
- discuss lectins used for analysis of rheumatoid arthritis
- identify glycan epitope as a biomarker for rheumatoid arthritis

### 2. Method for Determining Disease Activity of Rheumatoid Arthritis of the Present Invention

- define biomarker for rheumatoid arthritis
- describe detection and quantification of glycan epitope
- introduce glycosylation discrimination index
- explain detection and quantification by lectin array or sandwich ELISA method
- describe lectin array analysis method
- describe purification method
- introduce labeling substances
- prepare lectin array
- apply test sample to lectin array
- describe detection method
- introduce sandwich method
- describe capture agent and detection agent
- outline measurement methods
- describe detection and discrimination method

### 3. Kit for Determination of Disease Activity of Rheumatoid Arthritis

- describe kit composition

### 4. A Diagnosing Method for Accurately Discriminating Similar Rheumatic Diseases, and Diagnostic Kit for the Method

- motivate lectin-based diagnosis
- describe diagnostic method and kit

## EXAMPLES

- introduce examples of the present invention

### (Example 1) Measurement of the Abundance of MMP-3 in Serum Sample

- describe simplified fractionation and concentration of MMP-3 in serum
- perform Western blotting to estimate recovered amount of each sample

### (Example 2) Glycan Profiling by Antibody-Overlay-Lectin Array

- apply comparative glycan profiling to MMP-3 in serum sample
- examine MMP-3 glycan changes associated with rheumatism

### (Example 3) Comparative Analysis Between Acquired Data and Clinical Parameters

- examine correlation between lectin signals and clinical parameters

### (Example 4) Influence of Sialidase Digestion on Glycan Profile

- enrich MMP-3 in serum and perform sialidase digestion
- examine influence on glycan profile after sialidase digestion

### (Example 5) Glycan Profiling of MMP-3 in Synovial Fluid

- examine glycan profile of MMP-3 released into synovial fluid

### (Example 6) Ability to Discrimination of MMP-3 Positive Diseases

- compare reactivity with MMP-3 O-linked glycan
- analyze lectin signals for disease discrimination
- create indexes for RA detection

